Botanical name: Coptis chinensis
Common name: Coptis, Chinese goldthread 
Plant part: Rhizome
Strength: 1:2
Source (Organic or Trade): Trade
Country of Origin: China
Weekly Dosage (mL): 20-50mL 

Actions: Antimicrobial, Antioxidant, Anti- inflammatory, Endocrine modulator

Main indication: Bacterial infection, irritable bowel syndrome, metabolic syndrome, viral and fungal infections, H. pylori infections 

Safety information: Berberine-containing plants are not recommended for use during pregnancy or during lactation due to their potential for causing uterine contractions and bilirubin stimulation.

More Information: Coptis Technical Sheet

Article: 1. Liu l et al, Mol 2016; 21, 913 2. Friedemann T et al, Evid Based Comp Alt Med 2015; 827308, 9
3. Pizzorno & Murray, Textbook Nat Medicine, 4th Ed 2013
4. Ho CE et al, Evid Based Comp Alt Med 2014; 871720, 7
5. Kamath S et al, Chinese Medicine 2009; 4(1)
6. Hayashi K et al, Bio Med Chem Let 2007; 17(6), 1562-1564
7. Shin HB et al, Int Immunopharm 2015; 27(1), 65-68
8. Song S et al, Antimicrob Agents Chemothera 2014; 58(9), 5068-5078
9. Jia F, Arch Virol. 2010;155(8):1325-9
10. Liu Y et al, Evid Based Comp Alternat Med. 2017; 2017: 8943059
11. Dong H et al, Planta Medica 2013; 79(6), 437-446
12. Cao Y et al, Phytomedicine 2012; 19(8-9), 686-692
13. Wu H et al, Phytomedicine 2014; 21(11), 1373-1381
14. Wang H et al, Biomed Res Int 2014; 798093
15. Prabhakar PK et al, Chin J Integr Med 2011; 17(8):563-74
16. Yarnell & Abascal, J Alt Comp Thera 2006; 12(6), 303-309
17. Zhao L et al, Fertility & Sterility 2011; 95(1), 461-463
18. Wei W et al, Eur J Endocr 2012; 166(1), 99-105
19. An Y et al, Clin Endocr 2014; 80(3), 425-431
20. Wu LT et al, Curr Microbio 2005; 51(4), 255-261.
21. Shi C et al, J Vet Sci 2018;19(6):808-816
22. Sack & Froelich, Inf Immun 1982; 35(2), 471-475
23. Habtemariam S, Pharmacol Res. 2016; 113(Pt A):592-599
24. Ciu H et al, Front Pharmacol 2018; 31;9:571
25. Magesh H et al, ind j Exper Biol 2013; 51(9), 764-772
26. Arjoon AV et al, BMC Complement Altern Med. 2012; 12: 169
27. Li J et al, http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZYHS200808075.htm
28. Da Silva AR, et al Antimicrob Agents Chemothe 2016; 23;60(6):3551-7
29. Zhou XY et al, J Antibiot (Tokyo) 2016;69(10):741-746
30. Morita Y et al, Front Microbiol 2016; 5;7:1223
31. Li Y et al, Cell Physiol Biochem 2017; 42(4):1657-1669
32. Tan L et al, Eur J Pharm Sci 2017; 15;110:77-86
33. Budeyri Gokgoz N et al, Microb Drug Resist. 2017; 23(5):531-544
34. Su SL et al, Lishizhen Medicine and Materia Medica Research, 03
35. Kaneda Y et al, Tokai J Exp Clin Med; 15(6), 417-423
36. Choudhry VP et al, Amer j Dis Child 1975; 129(7) 866
37. Pang B et al, Evid Based Comp Alt Med 2015; 921416, 10
38. Xu Y et al; Ind J Pharma Sci 2013; 75(3), 270
39. Wang N et al, J Ethnopharmacol 2015; 24;176:35-48
40. Wang XJ et al, BMC Complement Altern Med 2013; 15;13
41. Lee JW et al, J Microbiol Biotechnol. 2018;28(6):839-848
42. Liu D et al, Front Pharmacol 2019; 14;10:9